A regional infant health programme in Ireland has delivered a striking result: nearly nine in 10 eligible newborns in the Mid West received protection against RSV before leaving hospital. The update, published via the Health Service Executive (HSE), points to a practical model for how preventive care can be embedded into maternity services and scaled through public health systems.
The study focused on babies born at University Maternity Hospital Limerick between September 2024 and February 2025, during Ireland’s first universal newborn RSV immunisation pilot. Researchers found that 89.4% of eligible infants received nirsevimab, a long-acting antibody designed to reduce the risk of severe respiratory syncytial virus infection in early life.
Health Service Executive (HSE) pilot delivers high RSV uptake
The Health Service Executive (HSE) programme matters because RSV is a major cause of bronchiolitis and infant hospital admission, especially during the winter season. Pressure from RSV affects GPs, paediatric wards, emergency departments and intensive care capacity, making prevention a key issue for Health planning and wider public service delivery.
According to the published findings, 1,790 newborns were included in the analysis, with more than 80% of protected babies receiving nirsevimab within four days of birth. That speed of delivery suggests the Mid West model worked because immunisation was integrated into routine maternity and neonatal care rather than treated as a separate follow-up service.
- 89.4% uptake among eligible newborns
- 1,790 infants included in the study
- Most doses given within four days of birth
- Programme delivered through a single regional maternity hub
This kind of outcome is relevant not just to the Health Service Executive (HSE), but also to policymakers across gov.ie departments involved in Health, Social Protection and Public Expenditure, where prevention can reduce downstream system costs.
Read more: Irish health service digital care trends
What the findings mean for families and the wider health system
The strongest message from the Health Service Executive (HSE) update is reassurance for parents. RSV can affect otherwise healthy infants, and severe cases often arrive quickly in the first vulnerable months after birth. Offering protection before discharge simplifies access for families and reduces the need for additional appointments.
National pilot data also strengthens the case for expansion. Compared with the same period in 2023/24, officials reported major declines in RSV impact, including fewer notifications, lower emergency department attendance, and reduced hospital and ICU admissions. For a system under seasonal pressure, this is the kind of early intervention that can support hospitals while improving infant outcomes.
The success of the Mid West programme also reflects strong coordination among midwives, neonatal teams, pharmacy staff, clinicians and researchers. Similar cross-service implementation is often seen across Irish public bodies, from the Revenue Commissioners and Department of the Taoiseach to agencies such as HIQA and the Citizens Information Board, where policy only works when frontline delivery is clear and accessible.
Explore: How public health policy works in Ireland
Equity gaps still need attention
While the Health Service Executive (HSE) pilot achieved high overall uptake, researchers also identified an important challenge: lower participation among some minority ethnic communities, including infants born to Irish Traveller mothers. That finding highlights the need for culturally appropriate communication, trusted local engagement and targeted information during future rollout.
Equity is a recurring issue across many public services, whether in Education, Housing, Justice or healthcare access. For the Health Service Executive (HSE), the next phase is not just about maintaining high uptake, but ensuring that every eligible family can benefit equally regardless of background, language or service familiarity.
- Improve translated and culturally tailored information
- Support community-led awareness efforts
- Train staff on inclusive communication
- Monitor uptake by demographic group in future programmes
Read more: Health equity and community outreach strategies
Why this matters for national policy
The Health Service Executive (HSE) results provide a roadmap for broader newborn protection programmes in Ireland. A hospital-based model with clear workflows, staff leadership and public awareness support can deliver strong uptake at scale. That is valuable for government planning across gov.ie, especially where Health and Finance decisions increasingly focus on prevention, resilience and measurable outcomes.
For parents, the takeaway is simple: early RSV protection can make a meaningful difference. For policymakers, the Health Service Executive (HSE) pilot shows that well-designed newborn prevention can reduce severe illness and relieve strain on healthcare services when winter demand peaks.
